7,560 Shares in Agilent Technologies, Inc. $A Purchased by 111 Capital

111 Capital purchased a new position in Agilent Technologies, Inc. (NYSE:A) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 7,560 shares of the medical research company’s stock, valued at approximately $1,029,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in A. Brighton Jones LLC grew its position in Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after acquiring an additional 270 shares in the last quarter. Jones Financial Companies Lllp boosted its position in shares of Agilent Technologies by 15.9% during the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after buying an additional 769 shares during the period. Geneos Wealth Management Inc. boosted its position in shares of Agilent Technologies by 54.8% during the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after buying an additional 212 shares during the period. Acadian Asset Management LLC boosted its position in shares of Agilent Technologies by 16.5% during the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after buying an additional 758 shares during the period. Finally, Sivia Capital Partners LLC purchased a new position in shares of Agilent Technologies during the second quarter valued at approximately $273,000.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on A. Barclays lifted their price target on shares of Agilent Technologies from $140.00 to $145.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. UBS Group decreased their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a research note on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price target for the company. Wells Fargo & Company reduced their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Finally, Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and reduced their price objective for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $161.71.

Agilent Technologies Price Performance

NYSE A opened at $135.51 on Friday. The firm’s fifty day simple moving average is $118.35 and its two-hundred day simple moving average is $128.35. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The firm has a market capitalization of $38.27 billion, a P/E ratio of 27.21, a P/E/G ratio of 2.46 and a beta of 1.26.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. The firm had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts forecast that Agilent Technologies, Inc. will post 5.99 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is presently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.